Press Releases
Amyris delivers high-performance alternatives to petroleum, plant and animal-based products across a wide range of consumer and industry segments. Our products offer customers a way to reduce environmental impact with No Compromise® in performance or availability. We are making better chemistry biologically.
-
Nov 7, 2019- Q3 2019 GAAP revenue of $35.0 million, up 144% over GAAP revenue of $14.3 million for Q3 2018
-
Oct 10, 2019Continues Industry Leading Revenue Growth with Strong Margins
-
Oct 1, 2019Delivers 134% Revenue Growth Over First Half 2018; Files 2018 Form 10-K
Sep 4, 2019Following the success of Amyris's Biossance brand, Pipette is setting the standard for clean, safe, and transparent care for the most vulnerable skin
Jul 19, 2019- Contract expanded to 2020 with ADL revenues anticipated to exceed EUR 12 million
-
Jun 4, 2019FLG Partners Veteran Finance Professional to Ensure Smooth Transition and Execution of SEC Filings Compliance Process
-
May 15, 2019
-
Apr 18, 2019Exiting Vitamin E Simplifies Amyris and Improves Predictability
-
Mar 18, 2019LAVVAN Cites Amyris’s Proven Commercial Achievements and Capability to Bring to Market the Highest Quality Cannabinoids for Large Scale Use
-
Feb 12, 2019Sustainable Squalene Replacement Needed for Pharma
-
Feb 5, 2019Leadership and Track Record in Scaling Sustainable Fermentation-Based Commercial Products Leads to One of Largest Agreements to Date in Cannabinoid Market
Contact Us
Beth Bannerman
Senior Vice President, Corporate Communications & Engagement
Amyris, Inc.
pr@amyris.com